Institut Curie Announces Creation of Honing Biosciences
Institut Curie, a key player in the fight against cancer, announces the launch of the biotechnology company Honing Biosciences. The company owns an exclusive technology platform to develop solutions to optimize the efficacy and safety of cell therapy in cancer and chronic diseases. Initially, Honing Biosciences will focus on the strategic area of cancer immunotherapy, particularly CAR-T cells. By entering the capital of the start-up, Institut Curie marks its confidence in the development of Honing Biosciences and materializes its novel technology transfer policy implemented in 2017.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180917005059/en/
"CellTune ™ molecular technology allows the development of a new class of cell therapies by controlling the dynamic distribution of proteins in “cell-medicaments”. We can regulate the expression of proteins on the cell surface or the secretion of enzymes, cytokines and antibodies, to adapt the delivery of therapeutic proteins to patient clinical evolutions " says Franck Perez, co-founder of Honing Biosciences and CNRS Research Director at Institut Curie.
CAR-T cells show therapeutic efficacy in blood cancers, but can also be toxic. In solid tumors, there is still no conclusive result. Honing Biosciences’ technology allows considering the development of effective approaches, safe and affordable" says Sebastian Amigorena, scientific advisor of Honing Biosciences and Director of the Cancer Immunotherapy Center of Institut Curie.
“Honing Biosciences proprietary protein transport control technology shall attract partners in the cell therapy sector, a highly dynamic market that has been growing continuously for several years. This is an emblematic example of fundamental research that will ultimately benefit to patients treated at the Institute through the development of a start-up and reveals the institute entrepreneurial dynamics " says Amaury Martin, head of Institut Curie Technology Transfer and Industrial Partnerships Department and Director of the Carnot Institute Curie Cancer.
“Cell therapy is one of the major advances of recent years in research and especially in the fight against cancer. This is a rapidly changing market and we are seeing great interest in our proprietary technology from industry and investors. We will quickly identify the future partners of Honing Biosciences” concludes Abdelkader Bousabaa, co-founder and CEO of Honing Biosciences.
Hélène Bléher, +331 41 34 18 65
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Andersen Global Expands Africa Presence; Signs Collaboration Agreement in Economic Hub of South Africa18.4.2019 16:30:00 EEST | Tiedote
Andersen Global is excited to announce the addition of its first collaborating firm in South Africa. Tabacks Attorneys and Corporate Law Advisors, headquartered in Johannesburg, South Africa, has signed a Collaboration Agreement with Andersen Global, an international association of member and collaborating firms. South Africa marks the tenth country in Africa in which Andersen Global has a presence. Led by Chairman David Woodhouse, Tabacks has a team of 27 lawyers who offer legal assistance and commercial advice to a diverse clientele in construction, manufacturing, energy, mining, explosives, retail, hospitality, logistics, pharmaceutical, property and banking industries. The firm is considered a leading law firm in South Africa, and its practice areas include competition law, commercial law, mining, employment law, environmental health & safety law, tax and litigation. “The global economy is rapidly changing, which brings unique challenges to corporate and commercial law,” said David
Amazon and Google Announce Official YouTube Apps to Launch on Fire TV; Prime Video App Coming to Chromecast and Android TV18.4.2019 16:00:00 EEST | Tiedote
Today, Amazon (NASDAQ: AMZN) and Google (NASDAQ: GOOGL) announced that in the coming months, the two companies will launch the official YouTube app on Amazon Fire TV devices and Fire TV Edition smart TVs, as well as the Prime Video app for streaming to Chromecast and Chromecast built-in devices. In addition, Prime Video will be broadly available across Android TV device partners, and the YouTube TV and YouTube Kids apps will also come to Fire TV later this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190418005212/en/ “We are excited to work with Amazon to launch the official YouTube apps on Fire TV devices worldwide,” said Heather Rivera, Global Head of Product Partnerships at YouTube. “Bringing our flagship YouTube experience to Amazon Fire TV gives our users even more ways to watch the videos and creators they love.” “We’re excited to bring the Prime Video app to Chromecast and Android TV devices, and to give our c
KCI Files Registration Statement for Proposed Initial Public Offering18.4.2019 16:00:00 EEST | Tiedote
Acelity announced today that its affiliate, KCI Holdings, Inc. (“KCI”), filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”), relating to a proposed initial public offering of KCI’s common stock. Prior to the effectiveness of the registration statement, there will be a restructuring as a result of which KCI will become the holding company of the businesses currently conducted by Acelity L.P. Inc. and its subsidiaries. The number of shares to be offered and the price range for the proposed offering have not yet been determined. J.P. Morgan, Goldman Sachs & Co. LLC and BofA Merrill Lynch are acting as joint book-running managers for the proposed offering. The offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus related to the offering may be obtained from: J.P. Morgan, Attention: Prospectus Department c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, via tele
Strasbourg Approves the Covered Bond Legislative Package: a Milestone for the Future of the Industry and the Capital Markets Union18.4.2019 15:06:00 EEST | Tiedote
Following the trilogue negotiations with the Council and the European Commission on the proposal for a Covered Bond Legislative Package, the European Parliament’s Plenary adopted today in Strasbourg the text which had been approved by the Council (Coreper) on 20 March and then by the European Parliament’s Economic and Monetary Affairs (ECON) Committee on 1 April 2019. In this context, the European Mortgage Federation - European Covered Bond Council (EMF-ECBC ) welcomes the adoption of the Covered Bond Legislative Package, which aims at completing the Capital Markets Union (CMU) in Europe. The Package provides a basis for enhanced harmonisation of the European covered bond market, in line with the objectives of the CMU, reinforcing a European common qualitative benchmark for international investors and respecting well-functioning traditional markets. It moreover paves the way for the smooth introduction of this asset class in newer and emerging covered bond markets in the Union, such as
Schlumberger Announces First-Quarter 2019 Results18.4.2019 14:00:00 EEST | Tiedote
Schlumberger Limited (NYSE: SLB) today reported results for the first quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2019 Dec. 31, 2018 Mar. 31, 2018 Sequential Year-on-year Revenue $7,879 $8,180 $7,829 -4% 1% Pretax operating income $908 $967 $974 -6% -7% Pretax operating margin 11.5 % 11.8 % 12.4 % -30 bps -91 bps Net income - GAAP basis $421 $538 $525 -22% -20% Net income, excluding charges & credits* $421 $498 $525 -15% -20% Diluted EPS - GAAP basis $0.30 $0.39 $0.38 -23% -21% Diluted EPS, excluding charges & credits* $0.30 $0.36 $0.38 -17% -21% North America revenue $2,738 $2,820 $2,835 -3% -3% International revenue $5,037 $5,283 $4,883 -5% 3% North America revenue, excluding Cameron $2,178 $2,265 $2,285 -4% -5% International revenue, excluding Cameron $4,469 $4,581 $4,147 -2% 8% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Fir
IDEMIA Provides NOS with eSIM Management Solutions18.4.2019 13:49:00 EEST | Tiedote
At the occasion of the launch of the first ever eSIM (embedded SIM) service on the Portuguese market, NOS today introduces with IDEMIA an eSIM subscription management commercial service for the consumer market, based on a physical voucher approach and future evolution towards a digital voucher. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190418005321/en/ (Photo: IDEMIA) As a major actor in the telecom field, IDEMIA is at the forefront of the digital revolution and is committed to bringing protected and convenient experiences to mobile operator customers. IDEMIA will be providing NOS its eSIM management solutions that will provide instant digital connectivity that allows users to connect any electronic device straight out-of-the-box and link multiple devices to the same mobile subscription. eSIM offers a streamlined user experience when it comes to managing cellular connectivity for Enterprises. According to ABI Research,
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme